(S)-4-Chloro-8-oxo-7-{2-oxo-2-[4-(2-oxo-1,2,4,5-tetrahydro-benzo[d][1,3]diazepin-3-yl)-piperidin-1-yl]-ethyl}-9-(2,2,2-trifluoro-ethyl)-3,6,7,8,9,10-hexahydro-3,9-diaza-cyclohepta[e]indene-1-carbonitrile

ID: ALA4874451

PubChem CID: 164627588

Max Phase: Preclinical

Molecular Formula: C31H30ClF3N6O3

Molecular Weight: 627.07

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  N#Cc1c[nH]c2c(Cl)cc3c(c12)CN(CC(F)(F)F)C(=O)[C@H](CC(=O)N1CCC(N2CCc4ccccc4NC2=O)CC1)C3

Standard InChI:  InChI=1S/C31H30ClF3N6O3/c32-24-12-19-11-20(29(43)40(17-31(33,34)35)16-23(19)27-21(14-36)15-37-28(24)27)13-26(42)39-8-6-22(7-9-39)41-10-5-18-3-1-2-4-25(18)38-30(41)44/h1-4,12,15,20,22,37H,5-11,13,16-17H2,(H,38,44)/t20-/m0/s1

Standard InChI Key:  QBTCKQXNHLUUKF-FQEVSTJZSA-N

Molfile:  

 
     RDKit          2D

 44 49  0  0  0  0  0  0  0  0999 V2000
   16.8721  -29.8151    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   17.6687  -30.0297    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4542  -29.2320    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   21.8454  -27.3553    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.2499  -28.0652    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.0630  -28.0677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.4777  -27.3621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.0691  -26.6522    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2499  -26.6480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0241  -27.3546    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6119  -26.6425    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.6108  -28.0661    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7895  -28.0655    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4371  -28.7984    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6347  -28.9859    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.4358  -27.3243    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9900  -28.4763    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9917  -27.6562    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6340  -27.1406    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5095  -26.3301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7433  -26.0341    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2288  -27.3633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1051  -26.5516    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2947  -26.4155    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.9159  -27.1457    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4948  -27.7304    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9472  -29.4409    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.2963  -27.3684    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.6535  -26.6334    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.4566  -26.4531    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.6493  -28.1117    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.4510  -28.2956    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0992  -26.9590    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0946  -27.7811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.8037  -28.1964    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.5178  -27.7866    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.5184  -26.9614    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.8088  -26.5539    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.1425  -25.9883    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.4554  -29.7873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4879  -30.8322    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   17.6160  -25.2269    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   16.3634  -28.5351    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2306  -29.3414    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  5  1  0
  4  9  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  4 10  1  0
 10 11  2  0
 10 12  1  0
 13 12  1  1
 13 14  1  0
 14 15  1  0
 13 16  1  0
 15 17  1  0
 16 19  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 23  1  0
 22 18  1  0
 22 23  2  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 26 22  1  0
 14 27  2  0
 28 29  1  0
 29 30  1  0
 28 31  1  0
 30 33  1  0
 31 32  1  0
 32 34  1  0
  7 28  1  0
 33 34  2  0
 34 35  1  0
 35 36  2  0
 36 37  1  0
 37 38  2  0
 38 33  1  0
 29 39  2  0
 15 40  1  0
 40  2  1  0
  2 41  1  0
 21 42  1  0
 43 44  3  0
 26 43  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4874451

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 627.07

Molecular Weight (Monoisotopic): 626.2020

AlogP: 5.23

#Rotatable Bonds: 4

Polar Surface Area: 112.54

Molecular Species: NEUTRAL

HBA: 4

HBD: 2

#RO5 Violations: 2

HBA (Lipinski): 9

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 2

CX Acidic pKa: 12.60

CX Basic pKa: ┄

CX LogP: 3.47

CX LogD: 3.47

Aromatic Rings: 3

Heavy Atoms: 44

QED Weighted: 0.41

Np Likeness Score: -0.57

References

1. Luo G, Jiang XJ, Chen L, Conway CM, Gulianello M, Kostich W, Keavy D, Signor LJ, Chen P, Davis C, Whiterock VJ, Schartman R, Widmann KA, Macor JE, Dubowchik GM..  (2021)  Calcitonin gene-related peptide (CGRP) receptor antagonists: Heterocyclic modification of a novel azepinone lead.,  43  [PMID:33932522] [10.1016/j.bmcl.2021.128077]

Source

Source(1):

• Scientific Literature